Conservative management in congenital severe bilateral hydronephrosis related to uretero-pelvic junction obstruction

S. Arena, R. Chimenz, A. Centorrino, I. Salamone, M.G. Scuderi, F.M. Peri, G. Stroscio, D. Impollonia, V. Di Benedetto, U. Calabrese, P. Impellizzeri, C. Romeo

Article ID: 6794
Vol 33, Issue 5S1, 2019
DOI: https://doi.org/10.54517/jbrha6794
Received: 8 November 2019; Accepted: 8 November 2019; Available online: 8 November 2019; Issue release: 8 November 2019

Abstract

We report our experience in conservative management of patients with prenatal and neonatal diagnosis of severe bilateral ureteropelvic junction obstruction (UPJO), focusing on the actual predictors of renal function impairment or spontaneous resolution. Between 1996 and 2006, 20 patients with bilateral severe hydronephrosis related to UPJO were included in the study. Indications for surgery were an increased hydronephrosis, decreased renal function, onset of symptoms. Conservatively treated patients were followed up for 3 months to 10 years with renal ultrasound, DTPA diuretic, urine culture. At first renal scan, 22 out of 40 renal units had a poor, 10 an intermediary and 8 a good drainage. Pyeloplasty was required in 10 of the 40 kidneys, while 30 out of 40 kidneys were followed conservatively. At the end of follow up, sieric normalized creatinine and estimated glomerular filtration rate were normal in all patients. Our data showed that bilateral severe hydronephrosis related to UPJO can be safely managed in a similar manner of a unilateral case. A poor drainage could be considered a negative predictive factor in the feasibility of a conservative management.


Keywords

bilateral ureteropelvic junction obstruction;bilateral hydronephrosis;99mTc-DTPA renal scan;pyeoloplasty


References

Supporting Agencies



Copyright (c) 2019 S. Arena, R. Chimenz, A. Centorrino, I. Salamone, M.G. Scuderi, F.M. Peri, G. Stroscio, D. Impollonia, V. Di Benedetto, U. Calabrese, P. Impellizzeri, C. Romeo




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).